Contravisory Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,329
Closed -$327K 385
2023
Q3
$327K Buy
+1,329
New +$364K 0.09% 153
2022
Q3
Sell
-323
Closed -$54K 337
2022
Q2
$54K Sell
323
-7
-2% -$1.5K 0.02% 237
2022
Q1
$83K Buy
+330
New +$82.9K 0.02% 231
2015
Q4
Sell
-128,740
Closed -$9.96M 224
2015
Q3
$9.96M Sell
128,740
-765
-0.6% -$67.7K 2.34% 17
2015
Q2
$11.7M Buy
+129,505
New +$10.4M 2.56% 9

Other funds holding HCA

Contravisory Investment Management's HCA Position: Q4 2023 in Review

Contravisory Investment Management sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 1,329 shares — an estimated $327K sold.

Contravisory Investment Management first reported a position in HCA in Q2 2015 and held it in 5 quarters. The position peaked at $11.7M in Q2 2015. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Contravisory Investment Management reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 1,329 HCA Healthcare shares in Q4 2023, an estimated $327K.
  • Contravisory Investment Management first reported a position in HCA Healthcare in Q2 2015 and held it in 5 quarters.
  • Contravisory Investment Management's HCA Healthcare position peaked at $11.7M in Q2 2015.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Contravisory Investment Management's 13F filing for Q4 2023, filed 11 Jan 2024.